Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 691 AL 705

Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways

Krasnova IN, Justinova Z, Cadet JL.

Psychopharmacology (Berl). 2016 May;233(10):1945-62. doi: 10.1007/s00213-016-4235-8. Epub 2016 Feb 12.

[Impairment of Odor Recognition in Myotonic Dystrophy Type 1]

Masaoka Y.

Brain Nerve. 2016 Feb;68(2):145-50. doi: 10.11477/mf.1416200364.

[Early Detection of Manganese Intoxication Based on Occupational History and T1-weighted MRI]

Fukutake T, Yano H, Kushida R, Sunada Y.

Brain Nerve. 2016 Feb;68(2):175-80. doi: 10.11477/mf.1416200369.

Neuroimaging with magnetoencephalography: A dynamic view of brain pathophysiology

Wilson TW, Heinrichs-Graham E, Proskovec AL, McDermott TJ.

Transl Res. 2016 Sep;175:17-36. doi: 10.1016/j.trsl.2016.01.007. Epub 2016 Jan 25.

Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease

Petrou M, Davatzikos C, Hsieh M, Foerster BR, Albin RL, Kotagal V, Müller ML, Koeppe RA, Herman WH, Frey KA, Bohnen NI.

Acad Radiol. 2016 May;23(5):577-81. doi: 10.1016/j.acra.2015.07.014. Epub 2016 Feb 10.

Identifying clinical measures that most accurately reflect the progression of disability in Parkinson disease

Ellis TD, Cavanaugh JT, Earhart GM, Ford MP, Foreman KB, Thackeray A, Thiese MS, Dibble LE.

Parkinsonism Relat Disord. 2016 Apr;25:65-71. doi: 10.1016/j.parkreldis.2016.02.006. Epub 2016 Feb 2.

Oral biomarkers in exercise-induced neuroplasticity in Parkinson's disease

Mougeot JL, Hirsch MA, Stevens CB, Mougeot F.

Oral Dis. 2016 Nov;22(8):745-753. doi: 10.1111/odi.12463. Epub 2016 Mar 28.

Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility

Zaveri NT.

J Med Chem. 2016 Aug 11;59(15):7011-28. doi: 10.1021/acs.jmedchem.5b01499. Epub 2016 Mar 14.

Parkinson's disease-related fatigue: A case definition and recommendations for clinical research

Kluger BM, Herlofson K, Chou KL, Lou JS, Goetz CG, Lang AE, Weintraub D, Friedman J.

Mov Disord. 2016 May;31(5):625-31. doi: 10.1002/mds.26511. Epub 2016 Feb 16.

An orthostatic hypotension mimic: The inebriation-like syndrome in Parkinson disease

Palma JA, Norcliffe-Kaufmann L, Kaufmann H.

Mov Disord. 2016 Apr;31(4):598-600. doi: 10.1002/mds.26516. Epub 2016 Feb 16.

Indoor and outdoor falls in persons with Parkinson's disease after 1 year follow-up study: differences and consequences

Gazibara T, Kisic-Tepavcevic D, Svetel M, Tomic A, Stankovic I, Kostic VS, Pekmezovic T.

Neurol Sci. 2016 Apr;37(4):597-602. doi: 10.1007/s10072-016-2504-2. Epub 2016 Feb 15.

Assessing medication role on neuropathological findings in Parkinson's disease

Adler CH, Hentz JG, Beach TG.

Mov Disord. 2016 May;31(5):613-4. doi: 10.1002/mds.26536. Epub 2016 Feb 16.

Imaging synucleinopathies

Brooks DJ, Tambasco N.

Mov Disord. 2016 Jun;31(6):814-29. doi: 10.1002/mds.26547. Epub 2016 Feb 16.

Integrated Approach for Pain Management in Parkinson Disease

Geroin C, Gandolfi M, Bruno V, Smania N, Tinazzi M.

Curr Neurol Neurosci Rep. 2016 Apr;16(4):28. doi: 10.1007/s11910-016-0628-7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias